We found that the frequency of PMN-MDSC was significantly decreased in metastatic LN and showed a tendency for the reduction in primary skin tumors from mice treated with the CXCR2 inhibitor as compared to control group (Figure 5C,D). Here, CXCR2 is linked to skin neoplasm.